Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,438.40    2.00 (0.14%)
Bid:
1,430.20
Ask:
1,430.40
Spread: 0.20 (0.014%)
Market Cap: £119.10b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Directorate Change

7 Nov 2019 07:10

RNS Number : 6134S
Rolls-Royce Holdings plc
07 November 2019
 

Rolls-Royce Holdings plc

7 November 2019

ROLLS-ROYCE APPOINTS GEORGE CULMER

AS A NON-EXECUTIVE DIRECTOR

Rolls-Royce today announces the appointment of George Culmer as a Non-Executive Director. He will join the Board with effect from 2 January 2020 and will become a member of the Nominations and Governance Committee, the Audit Committee and its sub-committee that considers cyber and data security and the Safety, Ethics and Sustainability Committee.

George is a qualified UK Chartered Accountant and until recently was Chief Financial Officer at Lloyds Banking Group (Lloyds), a FTSE 100 financial services company. During his time with Lloyds, George helped deliver a strong, sustainable financial performance. He played a key role in the bank's transformation and restoration to public ownership. George is also a non-executive director of Aviva plc.

Prior to his appointment at Lloyds, George served as Group Financial Officer at RSA Insurance Group (RSA) from 2004 to 2012. Before joining RSA, he held finance roles at Zurich Financial Services both in the UK and Switzerland between 2000 and 2004. Prior to this, George spent ten years with Prudential, where he was Head of Investor Relations and then Group Financial Controller. George began his career as an accountant with PwC and has a degree in history from the University of Cambridge.

Ian Davis, Chairman of Rolls-Royce, said: "I am delighted to welcome George to our Board. He has well rounded finance experience gained in large international, highly regulated groups and has proven business leadership credentials. We are looking forward to working with him."

George Culmer said: "I am delighted to be joining the Rolls-Royce Board. I am looking forward to making a contribution to the future of this pre-eminent brand."

Save as disclosed above, there are [no] further details to disclose under paragraphs 9.6.13 R (1) to (6) of the Listing Rules in respect of George Culmer.

 

 

About Rolls-Royce Holdings plc

1. Rolls-Royce pioneers cutting-edge technologies that deliver clean, safe and competitive solutions to meet our planet's vital power needs.

2. Rolls-Royce has customers in more than 150 countries, comprising more than 400 airlines and leasing customers, 160 armed forces, 70 navies, and more than 5,000 power and nuclear customers.

3. Annual underlying revenue was £15 billion in 2018, around half of which came from the provision of aftermarket services.

4. In 2018, Rolls-Royce invested £1.4 billion on research and development. We also support a global network of 29 University Technology Centres, which position Rolls-Royce engineers at the forefront of scientific research.

5. The Group has a strong commitment to apprentice and graduate recruitment and to further developing employee skills.

 

For further information, please contact:

Investors:

 

Peter Lapthorn

Investor Relations Manager

Rolls-Royce plc

Tel +44 (0) 20 7227 9079

+44 (0) 7717 811069

peter.lapthorn@rolls-royce.com

 

Media:

 

Richard Wray

Director of External Communications & Brand

Rolls-Royce plc

Tel +44 (0) 20 7227 9163

+44 (0) 7974 918416

richard.wray@rolls-royce.com

 

 

www.Rolls-Royce.com

 

Rolls-Royce Holdings plc LEI: 213800EC7997ZBLZJH69

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGGPAGUPBUQM
Date   Source Headline
2nd Apr 20259:00 amRNSTotal Voting Rights
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20254:30 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 202512:00 pmRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20251:00 pmRNSDirector/PDMR Shareholding
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20253:00 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20255:00 pmRNSHolding(s) in Company
11th Mar 20259:30 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20259:02 amRNSAGM Statement
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20253:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20259:37 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:05 amRNSShare buyback programme of up to £1 billion
27th Feb 20257:00 amRNSFull Year Results 2024
10th Feb 20252:30 pmRNSDirector/PDMR Shareholding
4th Feb 20253:30 pmRNSTotal Voting Rights
28th Jan 202511:30 amRNSDirector/PDMR Shareholding
9th Jan 202511:30 amRNSDirector/PDMR Shareholding
11th Dec 202410:00 amRNSDirector/PDMR Shareholding
22nd Nov 20241:00 pmRNSDirector Declaration
11th Nov 20241:30 pmRNSDirector/PDMR Shareholding
7th Nov 20247:00 amRNSTrading Update
9th Oct 20249:05 amRNSDirector/PDMR Shareholding
26th Sep 202412:00 pmRNSDirector/PDMR Shareholding
16th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20249:15 amRNSDirector/PDMR Shareholding
28th Aug 20242:05 pmRNSDirector/PDMR Shareholding
16th Aug 20241:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.